Advertisement
Journal Home
Search for

Issue

Free This issue is open to the public.

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

American Heart Journal
Volume 156, Issue 2, Supplement (August 2008)
Platelet Inhibitor Therapy: Current Perspectives and Emerging Novel Agents
Edited by Dominick J. Angiolillo MD, PhD, Eric R. Bates MD
Sponsored by Daiichi Sankyo, Inc. and Eli Lilly and Company

display abstract citation download email a colleague
Display:


Platelet inhibitor therapy: Current perspectives and emerging novel agents: Introduction
Dominick J. Angiolillo, Eric R. Bates
pages 1S-2S
Abstract | Full Text | Full-Text PDF (60 KB)


Current antiplatelet therapies: Benefits and limitations
Dominick J. Angiolillo, Luis A. Guzman, Theodore A. Bass
pages 3S-9S
Abstract | Full Text | Full-Text PDF (205 KB)


Pharmacology of emerging novel platelet inhibitors
Dominick J. Angiolillo, Piera Capranzano
pages 10S-15S
Abstract | Full Text | Full-Text PDF (389 KB)


Clinical profile of prasugrel, a novel thienopyridine
Dominick J. Angiolillo, Eric R. Bates, Theodore A. Bass
pages 16S-22S
Abstract | Full Text | Full-Text PDF (348 KB)


Clinical overview of promising nonthienopyridine antiplatelet agents
Dominick J. Angiolillo, Luis A. Guzman
pages 23S-28S
Abstract | Full Text | Full-Text PDF (119 KB)

Frontmatter


Table of Contents
page A2
Full-Text PDF (49 KB)

display abstract citation download email a colleague
Display:
Advertisement